Cardiac Biomarker Testing Market: Size, Growth, and Future Trends
In recent years, cardiac biomarker testing has become a cornerstone in the diagnosis and management of cardiovascular diseases (CVDs). This market, valued at USD 4.68 billion in 2023, is expected to grow significantly, with a CAGR of 8.8%, reaching USD 9.99 billion by 2032. This blog will take you through the factors driving this market,…